AMELIA WILLIAMS: Open Payments
NPI 1215162268 · BELLVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$508 in 27 payments from 10 companies in 2025. Trend: 2023 $825 · 2024 $725 · 2025 $508
Food & beverage: $508
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $107 |
| Amgen Inc. | 4 | $76 |
| ABBVIE INC. | 3 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $60 |
| Axsome Therapeutics, Inc. | 4 | $58 |
| Corcept Therapeutics | 2 | $40 |
| Exact Sciences Corporation | 2 | $37 |
| Boston Scientific Corporation | 1 | $27 |
| Dexcom, Inc. | 1 | $25 |
| Esperion Therapeutics, Inc. | 1 | $16 |
Products named: AIRSUPRA, VRAYLAR, TRINTELLIX, Auvelity, OTEZLA, Korlym, Cologuard Collection Kit, FARXIGA.
Industry payments across TX — which companies pay providers there.
